Advanced glycosylation end products induce nitric oxide synthase expression in C6 glioma cells: Involvement of a p38 MAP kinase-dependent mechanism

Pharmacology, Toxicology and Pharmaceutical Science

• Advanced Glycation End Product 100%
• Mitogen Activated Protein Kinase P38 100%
• Nitric Oxide Synthase 100%
• Inducible Nitric Oxide Synthase 54%
• Nitrite 45%
• Genistein 18%
• SB 203580 18%
• Tyrphostin 18%
• Mitogen Activated Protein Kinase P38 Inhibitor 9%
• Mitogen Activated Protein Kinase 9%
• Arginine Methyl Ester 9%
• Synthetase 9%
• Dactinomycin 9%
• Protein Tyrosine Kinase Inhibitor 9%
• Protein Tyrosine Kinase 9%
• Protein Farnesyltransferase Inhibitor 9%

Neuroscience

• Advanced Glycation End Product 100%
• P38 Mitogen-Activated Protein Kinases 100%
• Nitric Oxide Synthase 100%
• Inducible Nitric Oxide Synthase 54%
• Genistein 18%
• Synthetase 9%
• Protein Expression 9%
• Mitogen-Activated Protein Kinase 9%
• Cell Signaling 9%
• Tyrosine Kinase Inhibitor 9%
• Protein Kinase Inhibitor 9%
• Arginine Methyl Ester 9%
• Receptor Tyrosine Kinase 9%
• Actinomycin 9%
• Tyrosine Kinase 9%
• Farnesyltransferase Inhibitor 9%

Biochemistry, Genetics and Molecular Biology

• Nitric Oxide Synthase 100%
• Glycosylation 100%
• Mitogen-Activated Protein Kinase 100%
• P38 Mitogen-Activated Protein Kinases 36%
• Genistein 18%
• Signal Transduction 9%
• Protein Expression 9%
• Upregulation 9%
• Tyrosine Kinase 9%
• Arginine 9%
• Mediator 9%
• Farnesyltransferase 9%
• Tyrosine Kinase Inhibitor 9%
• Receptor Tyrosine Kinase 9%
• Monospecific Antibody 9%
• Dactinomycin 9%